WST

West Pharmaceutical Services, Inc.

$412.55

-0.07%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products.

Source: Yahoo Finance
AI summary

Price & performance

1M+11.3%
3M+21.5%
YTD+49.6%
1Y+48.6%
52-week range—
Beta0.62
Full chart and returns against a benchmark

Q-Score

63/ 100

Quality against peers; 50 is the peer median.

Growth59
Risk65
Performance53
Valuation44
Profitability74
Leverage74
Sentiment76
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$3.1B+6.3%
Net income$493.7M+0.2%
Net margin16.1%-1.0 pts
Historical fundamentals

Red flags in filings

1active red flag
Cybersecurity incidentMay 11, 2026
Filings, findings and the timeline

Revenue exposure

57%of revenue from outside the US
United States43%
Other Europe Countries15%
Germany12%
Largest customer100%
Regions, segments, customers and suppliers

Valuation

WSTIndustryP/E44.9849.36P/S8.463.73EV/EBITDA29.5323.12P/B9.683.92PEG1.501.50
Dividend yield0.22%
Every valuation metric

Earnings

Oct 29next report, before the open
EPS estimate$2.20
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate